Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 250


Deregulation of small non-coding RNAs at the DLK1-DIO3 imprinted locus predicts lung cancer patient outcome.

Enfield KS, Martinez VD, Marshall EA, Stewart GL, Kung SH, Enterina JR, Lam WL.

Oncotarget. 2016 Nov 5. doi: 10.18632/oncotarget.13133. [Epub ahead of print]


Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis.

Marshall EA, Ng KW, Kung SH, Conway EM, Martinez VD, Halvorsen EC, Rowbotham DA, Vucic EA, Plumb AW, Becker-Santos DD, Enfield KS, Kennett JY, Bennewith KL, Lockwood WW, Lam S, English JC, Abraham N, Lam WL.

Mol Cancer. 2016 Oct 27;15(1):67. Review.


Types of Control in Acupuncture Clinical Trials Might Affect the Conclusion of the Trials: A Review of Acupuncture on Pain Management.

Chen H, Ning Z, Lam WL, Lam WY, Zhao YK, Yeung JW, Ng BF, Ziea ET, Lao L.

J Acupunct Meridian Stud. 2016 Oct;9(5):227-233. doi: 10.1016/j.jams.2016.08.001. Review.


Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma.

Becker-Santos DD, Thu KL, English JC, Pikor LA, Martinez VD, Zhang M, Vucic EA, Luk MT, Carraro A, Korbelik J, Piga D, Lhomme NM, Tsay MJ, Yee J, MacAulay CE, Lam S, Lockwood WW, Robinson WP, Jurisica I, Lam WL.

J Pathol. 2016 Oct;240(2):161-72. doi: 10.1002/path.4765.


A comprehensively characterized cell line panel highly representative of clinical ovarian high-grade serous carcinomas.

Thu KL, Papari-Zareei M, Stastny V, Song K, Peyton M, Martinez VD, Zhang YA, Castro IB, Varella-Garcia M, Liang H, Xing C, Kittler R, Milchgrub S, Castrillon DH, Davidson HL, Reynolds CP, Lam WL, Lea J, Gazdar AF.

Oncotarget. 2016 Jun 10. doi: 10.18632/oncotarget.9929. [Epub ahead of print]


Microsurgical skill acquisition in a one-day introductory course with performance evaluation using software-assisted scoring system.

Stewart CJ, Yusoff SK, Widdowson D, Lam WL.

J Plast Reconstr Aesthet Surg. 2016 Jun;69(6):783-8. doi: 10.1016/j.bjps.2016.03.016.


Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma.

Cinegaglia NC, Andrade SC, Tokar T, Pinheiro M, Severino FE, Oliveira RA, Hasimoto EN, Cataneo DC, Cataneo AJ, Defaveri J, Souza CP, Marques MM, Carvalho RF, Coutinho LL, Gross JL, Rogatto SR, Lam WL, Jurisica I, Reis PP.

Oncotarget. 2016 May 17;7(20):28920-34. doi: 10.18632/oncotarget.8713.


Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer.

Clermont PL, Crea F, Chiang YT, Lin D, Zhang A, Wang JZ, Parolia A, Wu R, Xue H, Wang Y, Ding J, Thu KL, Lam WL, Shah SP, Collins CC, Wang Y, Helgason CD.

Clin Epigenetics. 2016 Feb 12;8:16. doi: 10.1186/s13148-016-0182-9.


Hydrogen Sulfide--Mechanisms of Toxicity and Development of an Antidote.

Jiang J, Chan A, Ali S, Saha A, Haushalter KJ, Lam WL, Glasheen M, Parker J, Brenner M, Mahon SB, Patel HH, Ambasudhan R, Lipton SA, Pilz RB, Boss GR.

Sci Rep. 2016 Feb 15;6:20831. doi: 10.1038/srep20831.


HPV status is associated with altered PIWI-interacting RNA expression pattern in head and neck cancer.

Firmino N, Martinez VD, Rowbotham DA, Enfield KS, Bennewith KL, Lam WL.

Oral Oncol. 2016 Apr;55:43-8. doi: 10.1016/j.oraloncology.2016.01.012.


Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression.

Crea F, Quagliata L, Michael A, Liu HH, Frumento P, Azad AA, Xue H, Pikor L, Watahiki A, Morant R, Eppenberger-Castori S, Wang Y, Parolia A, Lennox KA, Lam WL, Gleave M, Chi KN, Pandha H, Wang Y, Helgason CD.

Mol Oncol. 2016 May;10(5):693-703. doi: 10.1016/j.molonc.2015.12.010.


Piwi-interacting RNAs in cancer: emerging functions and clinical utility.

Ng KW, Anderson C, Marshall EA, Minatel BC, Enfield KS, Saprunoff HL, Lam WL, Martinez VD.

Mol Cancer. 2016 Jan 15;15:5. doi: 10.1186/s12943-016-0491-9. Review.


Gene expression analysis of microtubule affinity-regulating kinase 2 in non-small cell lung cancer.

Marshall EA, Ng KW, Anderson C, Hubaux R, Thu KL, Lam WL, Martinez VD.

Genom Data. 2015 Aug 30;6:145-8. doi: 10.1016/j.gdata.2015.08.011.


Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients.

Sunpaweravong P, Thu KL, Lam WL, Mai S.

J Cancer Res Clin Oncol. 2016 Apr;142(4):749-56. doi: 10.1007/s00432-015-2080-5.


The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.

Hansen CG, Ng YL, Lam WL, Plouffe SW, Guan KL.

Cell Res. 2015 Dec;25(12):1299-313. doi: 10.1038/cr.2015.140.


Macrophages, Inflammation, and Lung Cancer.

Conway EM, Pikor LA, Kung SH, Hamilton MJ, Lam S, Lam WL, Bennewith KL.

Am J Respir Crit Care Med. 2016 Jan 15;193(2):116-30. doi: 10.1164/rccm.201508-1545CI.


Variation in symptom distress in underserved Chinese American cancer patients.

Dhingra LK, Lam K, Cheung W, Shao T, Li Z, Van de Maele S, Chang VT, Chen J, Ye H, Wong R, Lam WL, Chan S, Bookbinder M, Dieckmann NF, Portenoy R.

Cancer. 2015 Sep 15;121(18):3352-9. doi: 10.1002/cncr.29497.


Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology.

Martinez VD, Vucic EA, Thu KL, Hubaux R, Enfield KS, Pikor LA, Becker-Santos DD, Brown CJ, Lam S, Lam WL.

Sci Rep. 2015 May 27;5:10423. doi: 10.1038/srep10423.


Microtubule affinity-regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non-small cell lung cancer.

Hubaux R, Thu KL, Vucic EA, Pikor LA, Kung SH, Martinez VD, Mosslemi M, Becker-Santos DD, Gazdar AF, Lam S, Lam WL.

Int J Cancer. 2015 Nov 1;137(9):2072-82. doi: 10.1002/ijc.29577.


Polycomb-mediated silencing in neuroendocrine prostate cancer.

Clermont PL, Lin D, Crea F, Wu R, Xue H, Wang Y, Thu KL, Lam WL, Collins CC, Wang Y, Helgason CD.

Clin Epigenetics. 2015 Apr 3;7:40. doi: 10.1186/s13148-015-0074-4.

Items per page

Supplemental Content

Support Center